VCYT
Veracyte, Inc.
November 4, 2026 · after-hours
- Rarity
- 4.68
- Peak move
- −23.84%
- Float cap
- $4.1B
Still running — rarity and peak move can only rise from here.
Veracyte, Inc. is a global diagnostics company that sells molecular diagnostic tests to clinicians and patients to guide cancer diagnosis, prognosis, and treatment. In the United States, it offers laboratory-developed tests through its CLIA-certified labs, including Decipher Prostate, Afirma, Prosigna, and Decipher Bladder. Outside the United States, it distributes in vitro diagnostic tests to laboratories and hospitals.
Where do you see this going?
no votes yetVote to see the split.
What we found
no events · 0 from SEC or newswire · 0 timed with the moveNot searched yet.A blank here does not mean there was no cause.